SCHEMBL223749

SCHEMBL223749

CCCCCCCCCCOC(=O)c1sc(C(=O)O)c(N)c1N

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.50
ALDH1A1 P00352 3/20 0.50
NPC1 O15118 2/20 0.50
RAB9A P51151 2/20 0.50
L3MBTL1 Q9Y468 3/20 0.48
LMNA P02545 3/20 0.48
ATM Q13315 2/20 0.48
GAA P10253 1/20 0.48
KDM4E B2RXH2 2/20 0.48
POLB P06746 2/20 0.48
HSD17B10 Q99714 1/20 0.48
GLA P06280 1/20 0.47
TSHR P16473 3/20 0.46
CYP3A4 P08684 2/20 0.44
TP53 P04637 1/20 0.44
MAPK1 P28482 1/20 0.44
ESR1 P03372 3/20 0.43
AKR1C4 P17516 1/20 0.43
AKR1C3 P42330 1/20 0.43
AKR1C2 P52895 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL223748 0.94 MAPT (0.55) MAPTALDH1A1NPC1RAB9AL3MBTL1
SCHEMBL2935502 0.76 ESR1 (0.49) ALDH1A1NPC1RAB9AL3MBTL1LMNA
SCHEMBL12204858 0.74 MAPT (0.62) MAPTALDH1A1NPC1RAB9AL3MBTL1
SCHEMBL27725035 0.74 RAB9A (0.48) MAPTALDH1A1NPC1RAB9AL3MBTL1
SCHEMBL8553334 0.72 PLA2G2A (0.51) TSHRTP53
SCHEMBL810866 0.72 ALDH1A1 (0.56) MAPTALDH1A1NPC1RAB9ALMNA
SCHEMBL11153151 0.72 ALDH1A1 (0.56) MAPTALDH1A1NPC1RAB9ALMNA
SCHEMBL2935501 0.72 ESR1 (0.54) ALDH1A1NPC1RAB9AL3MBTL1LMNA
SCHEMBL11499991 0.72 ALDH1A1 (0.56) MAPTALDH1A1NPC1RAB9ALMNA
SCHEMBL8545708 0.71 TSHR (0.55) MAPTALDH1A1NPC1RAB9AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120004386-A1 CONJUGATED THIOPHENES HAVING CONDUCTING PROPERTIES AND SYNTHESIS OF SAME UNIVERSITE DE MONTREAL (CA) 2012-01-05 US disclosed
US-8034895-B2 Conjugated thiophenes having conducting properties and synthesis of same Université de Montréal (CA) 2011-10-11 US disclosed
US-20070287842-A1 Conjugated Thiophenes Having Conducting Properties and Synthesis of Same UNIVERSITE DE MONTREAL (CA) 2007-12-13 US disclosed
WO-2005073265-A1 CONJUGATED THIOPHENES HAVING CONDUCTING PROPERTIES AND SYNTHESIS OF SAME UNIVERSITE DE MONTREAL (CA) 2005-08-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070287842-A1 Conjugated Thiophenes Having Conducting Properties and Synthesis of Same DDT, DDC, TRPA1 MAPT 233/4885ALDH1A1 91/4885NPC1 3326/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.